Drugs / S 95010
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03494712 | Feb 2018 → Apr 2019 | cardiovascular disorder | Servier | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S 95010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03494712 ↗ |
| Route | Intravenous | “After Single Escalating Intravenous Doses” NCT03494712 ↗ |